Related references
Note: Only part of the references are listed.PRODH/POX-Dependent Celecoxib-Induced Apoptosis in MCF-7 Breast Cancer
Magdalena Misiura et al.
PHARMACEUTICALS (2021)
Troglitazone-Induced PRODH/POX-Dependent Apoptosis Occurs in the Absence of Estradiol or ERβ in ER-Negative Breast Cancer Cells
Sylwia Lewoniewska et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Proline-Dependent Induction of Apoptosis in Oral Squamous Cell Carcinoma (OSCC)-The Effect of Celecoxib
Natalia Toloczko-Iwaniuk et al.
CANCERS (2020)
Anti-Inflammatory Drugs as Anticancer Agents
Silvia Zappavigna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Celecoxib in Cancer Therapy and Prevention - Review
Natalia Toloczko-Iwaniuk et al.
CURRENT DRUG TARGETS (2019)
Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses
James M. Phang
ANTIOXIDANTS & REDOX SIGNALING (2019)
The Proline Cycle As a Potential Cancer Therapy Target
John J. Tanner et al.
BIOCHEMISTRY (2018)
Ibuprofen reduces cell proliferation through inhibiting Wnt/ catenin signaling pathway in gastric cancer stem cells
Hassan Akrami et al.
CELL BIOLOGY INTERNATIONAL (2018)
Peroxisome Proliferator-Activated Receptors (PPAR) Agonists as Master Modulators of Tumor Tissue
Daniel Heudobler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine. conceptuses
Agnieszka Blitek et al.
THERIOGENOLOGY (2017)
PEPD is a pivotal regulator of p53 tumor suppressor
Lu Yang et al.
NATURE COMMUNICATIONS (2017)
PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux
Uddin Md. Nazim et al.
ONCOTARGET (2017)
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists
Shogo Okazaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies
Bahman Yousefi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy
Lisa Y. Pang et al.
STEM CELLS INTERNATIONAL (2016)
Proline Oxidase (POX) as A Target for Cancer Therapy
Joanna Kononczuk et al.
CURRENT DRUG TARGETS (2015)
Beyond Cox-Inhibition: 'Side-Effects' of Ibuprofen on Neoplastic Development and Progression
Paulo Matos et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study
Fatma M. Shebl et al.
PLOS ONE (2014)
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
Evrim Gurpinar et al.
FRONTIERS IN ONCOLOGY (2013)
Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment
Wei Liu et al.
AUTOPHAGY (2012)
COX2 overexpression is a prognostic marker for Stage III breast cancer
Hee Sung Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
Philip G. Conaghan
RHEUMATOLOGY INTERNATIONAL (2012)
The proline regulatory axis and cancer
James Ming Phang et al.
FRONTIERS IN ONCOLOGY (2012)
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Jeffrey M. Peters et al.
NATURE REVIEWS CANCER (2012)
PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation
Tamas Varga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer
Sarah S. Knox
CANCER CELL INTERNATIONAL (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
miR-23b*targets proline oxidase, a novel tumor suppressor protein in renal cancer
W. Liu et al.
ONCOGENE (2010)
Identification of a p53-response element in the promoter of the proline oxidase gene
Steve A. Maxwell et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The metabolism of proline as microenvironmental stress substrate
James M. Phang et al.
JOURNAL OF NUTRITION (2008)
Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers
Y. Liu et al.
ONCOGENE (2008)
Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators
Vincent Zoete et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis
Chien-an A. Hu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling
Y. Liu et al.
ONCOGENE (2006)
Proline oxidase, a proapoptotic gene, is induced by troglitazone -: Evidence for both peroxisome proliferator-activated receptor γ-dependent and -independent mechanisms
J Pandhare et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer
AT Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells
YM Liu et al.
CARCINOGENESIS (2005)
Celecoxib inhibits prostate cancer growth: Evidence of a cyclooxygenase-2-independent mechanism
MI Patel et al.
CLINICAL CANCER RESEARCH (2005)
Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention
AJ Dannenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells
G Eibl et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
S Grösch et al.
FASEB JOURNAL (2001)
Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction
B Rigas et al.
MEDICAL HYPOTHESES (2000)
Share Paper
